Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
Open Access
- 30 September 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 89 (7), 1270-1275
- https://doi.org/10.1038/sj.bjc.6601238
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Relevance of biologic markers in colorectal carcinomaCancer, 2002
- Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinomaInternational Journal of Cancer, 2001
- Proteolysis in human breast cancerMolecular Pathology, 2000
- Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lungPathology International, 1997
- Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast CarcinomasJapanese Journal of Cancer Research, 1996
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958